Back

Cross-kingdom miRNA delivery by Panax notoginseng-derived EVs restores neuronal function after ischemic injury

Mai, H.

2025-08-12 pharmacology and toxicology
10.1101/2025.08.08.669445 bioRxiv
Show abstract

The impermeability of the blood-brain barrier (BBB) remains a major obstacle to effective treatment of neurological disorders, particularly ischemic stroke. Here, we show that plant-derived extracellular vesicles (PEVs) offer a promising strategy to overcome this barrier. Using an optimized high-yield extraction protocol, we isolated PEVs from four medicinal plants--Panax ginseng, Panax notoginseng, Gastrodia elata, and Ligusticum chuanxiong. Among these, EVs derived from Panax notoginseng (NotoEVs) exhibited the strongest neuroprotective effects under hypoxic conditions in both in vitro and in vivo stroke models. Mechanistically, NotoEVs deliver conserved plant microRNAs to recipient neurons, where they suppress key stress granule nucleators (G3bp2, Ubap2l, Lsm14a), activate mTOR signaling, and promote mitochondrial stabilization via the BCL2/TOM20 axis. This cross-kingdom RNA delivery reprograms neuronal stress responses, reduces infarct volume, preserves neuronal morphology, and restores electrophysiological function. Together, our findings establish a scalable platform for plant-based nanotherapeutics and highlight the translational potential of NotoEVs for the treatment of ischemic stroke.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.